Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing neurodegenerative disease candidates, (the "Company" or "Cognition") ...
Strength in Dolby Atmos and Dolby Vision, synergies from acquisitions and focus on shareholder returns make DLB an attractive investment opportunity.
Cognition Therapeutics also worked with Arjuna Ratnayaka, Ph.D. in the School of Clinical and Experimental Sciences at the University of Southampton to conduct an in vitro study showing the potential ...
Handelsbanken Fonder AB lowered its holdings in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 23.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
Masked Analysis Shows Participants Receiving Oral Zervimesine for at Least 6 Months Experienced Slower Lesion Growth than Participants Receiving ...
After competing in regionals for the Northwest Conference (NWC) many wrestlers were given the opportunity to be awarded all ...
Research analysts at Zacks Research increased their Q2 2025 earnings per share estimates for shares of Dolby Laboratories in a note issued to investors on Wednesday, February 19th. Zacks Research ...
Extreme Cold Warning: Adams County, Billings County, Bottineau County, Bowman County, Burke County, Burleigh County, Divide ...
Intel is launching a whole range of new server processors. On request, these are also available with a thick Ethernet ...
Highlight,Updated earnings projections for Q2 2025 and future fiscal years by Zacks Research.,Steady market performance with ...
After meeting with CRVO’s management and analyzing its recent drug trial results, Boral believes that the company can improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results